Experiments for taxon Furcraea foetida (AGAVACEAE)

35 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
1068717	ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Furcraea foetida (AGAVACEAE)	HECOGENIN
1114333	TOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR	FISH POISON	Furcraea foetida (AGAVACEAE)
433764	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Furcraea foetida (AGAVACEAE)
433767	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIPROTOZOAN ACTIVITY	Furcraea foetida (AGAVACEAE)
433775	PHARMACOLOGY OF EXTRACT - IN VIVO	DIURETIC ACTIVITY	Furcraea foetida (AGAVACEAE)
248491	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATIN
1068716	PHYTOCHEMICAL SCREENING FORQUANTITATIVE DATA REPORTED		Furcraea foetida (AGAVACEAE)	O
1306462	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATINSPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)- O-BETA-GLUCOPYRANOSYL-(1→2)-O-[O- ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-5-ALPHA:FUROSTAN-12-ONE,25-(R)-3-BETA-D-[(O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSYL)OXY]-26-ALPHA-[(BETA-D-GLUCOPYRANOSYL)OXY]:
248486	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Furcraea foetida (AGAVACEAE)	FURCREASTATIN
433765	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Furcraea foetida (AGAVACEAE)
433776	PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE	TOXICITY ASSESSMENT(QUANTITATIVE)	Furcraea foetida (AGAVACEAE)
248484	VOUCHER SPECIMEN REPORTED FOR		Furcraea foetida (AGAVACEAE)
433774	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)
1306461	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FUROSTAN, 3-BETA-6-ALPHA-26-TRIYL TRIS-BETA-D-GLUCOPYRANOSIDE:25(R)-22-ALPHA-METHOXY-5-ALPHA:FUROSTAN-3-BETA-YL -O-BETA-D-GLUCOPYRANOSYL-(1 →3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-6-ALPHA-HYDROXY-22-ALPHA- -METHOXY-5-ALPHA:FUROSTAN-3-BETA-D-YL O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-22-ALPHA-METHOXY-5-ALPHA:SPIROSTANE-3-BETA-D-6-ALPHA-DIYL BIS-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-23-HYDROXY-5-ALPHA:SPIROSTAN-3 BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-LUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:24(S)-25(S)-24-[(BETA-D-GLUCOPYRANOSYL)OXY]-5-ALPHA:SPIROSTAN-6-ALPHA-YL-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-3-BETA-D-23-DIHYDROXY-5-ALPHA:SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-6-ALPHA-HYDROXY-5-ALPHA:SPIROSTAN-3-BETA-YL-BETA-D-FUCOPYRANOSIDE:23(S)-25(R)- 6-ALPHA-[(BETA-D--GLUCOPYRANOSYL)OXY]-23-HYDROXY-5- ALPHA:
248490	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATIN
433763	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Furcraea foetida (AGAVACEAE)
433768	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Furcraea foetida (AGAVACEAE)
248487	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATIN
433770	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Furcraea foetida (AGAVACEAE)
577099	MEDICINAL FOLKLORE REPORTED FOR	CARMINATIVE ACTIVITY	Furcraea foetida (AGAVACEAE)
1306460	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Furcraea foetida (AGAVACEAE)	FUROSTAN, 3-BETA-6-ALPHA-26-TRIYL TRIS-BETA-D-GLUCOPYRANOSIDE:25(R)-22-ALPHA-METHOXY-5-ALPHA:FURCREASTATINFUROSTAN-3-BETA-D-YL O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-22-ALPHA-METHOXY-5-ALPHA:SPIROSTANE-3-BETA-D-6-ALPHA-DIYL BIS-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-23-HYDROXY-5-ALPHA:SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)- O-BETA-GLUCOPYRANOSYL-(1→2)-O-[O- ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-5-ALPHA:SPIROSTAN-6-ALPHA-YL-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-3-BETA-D-23-DIHYDROXY-5-ALPHA:SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-6-ALPHA-HYDROXY-5-ALPHA:FUROSTAN-12-ONE,25-(R)-3-BETA-D-[(O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSYL)OXY]-26-ALPHA-[(BETA-D-GLUCOPYRANOSYL)OXY]:
248485	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)
433769	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Furcraea foetida (AGAVACEAE)
248488	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATIN
433773	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICONVULSANT ACTIVITY	Furcraea foetida (AGAVACEAE)
27789	PHARMACOLOGY OF EXTRACT - IN VIVO	INSECTICIDE ACTIVITY	Furcraea foetida (AGAVACEAE)
433772	PHARMACOLOGY OF EXTRACT - IN VIVO	ANALGESIC ACTIVITY	Furcraea foetida (AGAVACEAE)
577098	VOUCHER SPECIMEN REPORTED FOR		Furcraea foetida (AGAVACEAE)
433762	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Furcraea foetida (AGAVACEAE)
433766	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Furcraea foetida (AGAVACEAE)
433771	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTHERMIC ACTIVITY	Furcraea foetida (AGAVACEAE)
1306459	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Furcraea foetida (AGAVACEAE)	FUROSTAN-3-BETA-YL -O-BETA-D-GLUCOPYRANOSYL-(1 →3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-6-ALPHA-HYDROXY-22-ALPHA- -METHOXY-5-ALPHA:SPIROSTAN-3 BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-LUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:24(S)-25(S)-24-[(BETA-D-GLUCOPYRANOSYL)OXY]-5-ALPHA:SPIROSTAN-3-BETA-YL-BETA-D-FUCOPYRANOSIDE:23(S)-25(R)- 6-ALPHA-[(BETA-D--GLUCOPYRANOSYL)OXY]-23-HYDROXY-5- ALPHA:
433761	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Furcraea foetida (AGAVACEAE)
248489	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATIN
248492	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Furcraea foetida (AGAVACEAE)	FURCREASTATIN

Experiments for taxon Furcraea foetida (AGAVACEAE)

Experiments (35 results)

Filters

Worktypes (19)

Pharmacology (16)

Compounds (14)

Organisms (7)